Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prophylactic use of tranexamic acid in orthotopic liver transplantation: A randomized placebo-controlled study.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Mucosal Melanoma: Treatment Strategies for a Heterogeneous Disease.

Current pharmaceutical design·2026
Same author

Serum factor V and arterial lactate levels predict graft survival in liver transplant recipients with aminotransferase above five thousand.

World journal of transplantation·2025
Same author

Female donor gender is associated with a decrease in liver transplant survival of male recipients independent of donor and recipient anthropometrics.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery·2025
Same author

Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.

Life (Basel, Switzerland)·2025
Same author

Non-tumoral portal vein thrombosis in liver transplantation: Surgical perspectives and institutional protocol.

World journal of gastrointestinal surgery·2025

Related Experiment Video

Updated: Mar 18, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K

Treatment Strategies for Hepatocellular Carcinoma: When Less is Not More.

Gabriel Lazzarotto-da-Silva1, Fabiane A Marek1, Marcio F Chedid1

  • 1Liver Transplant and Hepatobiliary Surgery, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

Current Pharmaceutical Design
|March 16, 2026
PubMed
Summary

Combining therapies offers superior outcomes for hepatocellular carcinoma (HCC) treatment compared to single methods. This approach, including immune checkpoint inhibitors, is revolutionizing HCC management.

Area of Science:

  • Hepatobiliary Medicine
  • Surgical Oncology
  • Immunotherapy

Background:

  • Hepatocellular carcinoma (HCC) treatment involves surgery, locoregional therapies (LRT), and systemic therapies.
Keywords:
Hepatocellular carcinomaimmune checkpoint inhibitors.locoregional therapymicrowave ablationradiofrequency ablationtransarterial chemoembolization

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.4K

Related Experiment Videos

Last Updated: Mar 18, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.4K
  • Advanced HCC treatment has been enhanced by immune checkpoint inhibitors.
  • Optimizing treatment strategies for individual HCC patients remains a complex challenge.